{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "5 (83)",
                    "G2": "1 (17)"
                },
                "measures": "[G1, G2]",
                "outcomes": "[5 (83), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Red blood cells count decreased",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Leukopenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "2 (50)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (50), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Neutropenia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "AST increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "4 (100)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (100), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['100']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "4 (67)",
                    "G2": "1 (17)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[4 (67), 1 (17), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "ALT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "3 (75)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (75), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['75']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "1 (17)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 1 (17), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "GGT increase",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "2 (33)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 2 (33), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hypocalcemia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "1 (17)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 1 (17)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['17']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Hyponatremia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['50']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Nausea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "2 (50)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (50), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['33']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Vomiting",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "0 (0)",
                    "G2": "2 (33)",
                    "G3": "2 (33)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 2 (33), 2 (33)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Diarrhea",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "1 (25)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (25), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Abdominal pain",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "1 (25)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 1 (25)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Oral mucositis",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "2 (33)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[2 (33), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dyspepsia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "1 (17)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[1 (17), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Dysgeusia",
                    "dose level": "Level 2",
                    "n": "4",
                    "G1": "0 (0)",
                    "G2": "1 (25)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[0 (0), 1 (25), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['83']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['5']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Red blood cells count decreased",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Leukopenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Neutropenia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "AST increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['67']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['4']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "ALT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "GGT increase",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hypocalcemia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['17']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Hyponatremia",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['3']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['50']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Nausea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['25']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Vomiting",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 2",
                    "Sample Size": "4",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['1']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G1 count']",
                "outcomes": "['0']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G2 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 incidence']",
                "outcomes": "['33']"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Treatment related adverse events by dose level",
                    "adverse event": "Anorexia",
                    "dose level": "Level 1",
                    "n": "6",
                    "G1": "3 (50)",
                    "G2": "0 (0)",
                    "G3": "0 (0)"
                },
                "measures": "[G1, G2, G3]",
                "outcomes": "[3 (50), 0 (0), 0 (0)]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "AE": "Diarrhea",
                    "Treatment": "Dasatinib",
                    "Dose Level": "Level 1",
                    "Sample Size": "6",
                    "Grading System": "NCI-CTCAE v4.03"
                },
                "measures": "['G3 count']",
                "outcomes": "['2']"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 31,
    "total_ground_truth_claims": 126,
    "number_of_matches": 19
}